Carey Thomas D. 4
4 · EXACT SCIENCES CORP · Filed Aug 2, 2019
Insider Transaction Report
Form 4
Carey Thomas D.
Director
Transactions
- Sale
Common Stock
2019-07-31$114.99/sh−1,337$153,742→ 42,844 total - Sale
Common Stock
2019-07-31$119.30/sh−2,770$330,461→ 34,638 total - Sale
Common Stock
2019-07-31$115.89/sh−1,800$208,602→ 41,044 total - Sale
Common Stock
2019-07-31$117.33/sh−1,200$140,796→ 39,844 total - Sale
Common Stock
2019-07-31$120.19/sh−457$54,927→ 34,181 total - Sale
Common Stock
2019-07-31$118.21/sh−2,436$287,960→ 37,408 total
Footnotes (7)
- [F1]The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.51 to $115.34, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.52 to $116.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.72 to $117.72, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.81 to $118.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.85 to $119.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.13 to $120.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.